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Objective: Oxidative/nitrative stress, an imbalance between oxidant production and antioxidant 
defense in the biological system, is induced not only by various diseases but also by anesthesia 
and surgical trauma. Since the choice of drugs is expected to reduce oxidative/nitrative stress in 
the perioperative period, the lipid peroxidation inhibition by different drugs associated with 
surgery was studied together with investigating one of their possible mechanisms.  
Methods: Lipid peroxidation-inhibitory effects were fluorometrically determined using the 
liposomes of diphenyl-1-pyrenylphosphine-incorporated lipid bilayers which were treated with 
10-200 μM drugs and reference antioxidants, and then peroxidized with 20 μM peroxynitrite. 
Membrane interactions were evaluated by the drug- and antioxidant-induced changes in 
membrane fluidity which were determined by measuring the fluorescence polarization of 1,6-
diphenyl-1,3,5-hexatriene-labeled biomimetic membranes after treating with drugs and 
antioxidants at 1-200 μM.  
Results: All of the tested drugs concentration-dependently inhibited peroxynitrite-induced lipid 
peroxidation as well as antioxidant α-tocopherol, quercetin and (–)-epigallocatechin-3-gallate. 
The inhibition at 10 μM was greatest in propofol, followed by guaiacol, thiopental, thymol, 
phenol, midazolam, diazepam, lidocaine, eugenol, procaine, bupivacaine, ropivacaine, 
sevoflurane, ketamine, mepivacaine and prilocaine. Antioxidant drugs including propofol, local 
anesthetics and phenol derivatives, and reference antioxidants interacted with biomimetic 
membranes consisting of phospholipids and cholesterol to modify the membrane fluidity, while 
their membrane-interacting potencies did not necessarily correlate to their lipid peroxidation-
inhibiting ones, suggesting that the interaction between drugs and membrane lipid bilayers, at 
least in part, underlies the lipid peroxidation inhibition. 
Conclusion: In addition to their inherent effects, propofol and other drugs to inhibit lipid 
peroxidation may be protective against perioperative oxidative/nitrative stress. The membrane 
interaction could be a guide for discovering novel antioxidant drugs. 
© 2014 GESDAV 
 
INTRODUCTION 
The cause and consequences of a wide range of 
diseases are closely related to oxidative/nitrative stress, 
an imbalance between oxidant production and 
antioxidant defense in the biological system. Moreover, 
anesthesia and surgical trauma have been recognized to 
induce oxidative/nitrative stress [1-3]. Surgery is a 
pathological condition which enhances the generation 
of oxygen-derived reactive species and weakens the in 
vivo defense against their attacks. Oxidative/nitrative 
stress is implicated in ischemia-reperfusion injury and 
also referred to as one of major factors for 
postoperative morbidity and mortality. The antioxidant 
activity of perioperatively used drugs is of clinical 
interest because such activity is presumed to play a 
protective role against the pathological states associated 
with oxidative/nitrative stress [4]. 
Reactive oxygen/nitrogen species consisting of radicals 
and non-radicals are responsible for oxidative/nitrative 
stress. These reactive species damage membrane lipids, 
proteins, DNA and other biomolecules [5]. Lipid 
peroxidation of biological membranes is the primary 
event and its degree is used as an indicator of 
oxidative/nitrative stress. Oxidative/nitrative stress in 
the conditions of myocardial ischemia/reperfusion 
produces lipid peroxidation products [6]. Therefore, the 
choice of drugs with the antioxidant activity or the lipid 
peroxidation-inhibiting ability is expected to reduce 
oxidative/nitrative stress in the perioperative period 
[4, 7]. Since the antioxidant activity of drugs is 
commonly evaluated on the basis of lipid peroxidation 
inhibition by them, lipids have been frequently 
peroxidized in experiments with hydroxyl, ferryl, tert-
butyl hydroperoxide and 2,2’-azo-bis(2-amidinopro-
pane) dihydrochloride radicals [8, 9]. However, such 
experimental conditions do not reflect the in vivo lipid 
peroxidation. Biological oxidation situations produce 
nitric oxide and superoxide anion, both of which 
readily react to form a stronger oxidant peroxynitrite. 
Peroxynitrite is able to peroxidize membrane lipids and 
its ability is modulated by the antioxidant mechanism 
[10, 11]. Oxidative/nitrative stress induces the 
myocardial production of peroxynitrite to initiate the 
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cytotoxic processes like lipid peroxidation [12]. 
Oxidative/nitrative stress also affects biological 
membranes and the in vivo reaction of oxidants occurs 
at a lipid membrane level [13]. Peroxynitrite plays a 
crucial role in the membrane lipid peroxidation in 
myocardial ischemia/reperfusion [14]. 
The aim of this study was to verify the antioxidant 
activity of different drugs associated with surgery, 
anesthesia and perioperative use (structures of tested 
drugs and antioxidants are shown in Fig.1). Their 
inhibitory effects on peroxynitrite-induced lipid 
peroxidation were determined together with 
investigating their interactions with lipid bilayer 
membranes as one of possible antioxidant mechanisms. 
 
MATERIALS AND METHODS 
Reagents 
General anesthetics: propofol, thiopental sodium, 
diazepam, midazolam, ketamine and sevoflurane; local 
anesthetics: lidocaine, prilocaine, bupivacaine, 
ropivacaine, mepivacaine and procaine; phenol 
derivatives: phenol, guaiacol, eugenol and thymol; and 
reference antioxidants: alpha-tocopherol, quercetin and 
(–)-epigallocatechin-3-gallate (EGCG) were supplied 
by Aldrich (Milwaukee, WI, USA), Sigma (St. Louis, 
MO, USA), Wako Pure Chemicals (Osaka, Japan) or 
Tokyo Chemicals (Tokyo, Japan). Phospholipids:  
1-palmitoyl-2-oleoylphosphatidylcholine (POPC),  
1-palmitoyl-2-oleoylphosphatidylserine (POPS),  
1-palmitoyl-2-oleoylphosphatidylethanolamine (POPE) 
and porcine brain sphingomyelin (SM) were purchased 
from Avanti Polar Lipids (Alabaster, AL, USA), and 
cholesterol from Wako Pure Chemicals. Diphenyl-1-
pyrenylphosphine (DPPP) and peroxynitrite were 
obtained from Dojindo (Kumamoto, Japan), and  
1,6-diphenyl-1,3,5-hexatriene (DPH) from Molecular 
Probes (Eugene, OR, USA). Dimethyl sulfoxide 
(DMSO) of spectroscopic grade (Kishida; Osaka, 
Japan) was used for preparing reagent solutions. All 
other reagents were of the highest analytical grade 
available commercially. 
Lipid peroxidation inhibition 
The effects to inhibit lipid peroxidation were 
determined by the liposome system as reported 
previously [15]. In brief, an aliquot (0.25 ml) of ethanol 
solutions of 10 mM total lipids and 40 µM DPPP was 
repeatedly (four times) injected into 199 ml of 
Dulbecco’s phosphate-buffered saline of pH 7.4 
(Dainippon Pharmaceuticals; Osaka, Japan) to prepare 
DPPP-incorporated lipid bilayer membranes suspended 




Figure 1. Chemical structures of drugs and reference antioxidants used in this study. 
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liposomes was 11 mol% POPC, 11 mol% POPS, 16.5 
mol% POPE, 16.5 mol% SM and 45 mol% cholesterol. 
Liposome suspensions of 3.97 ml were incubated at 
37ºC for 30 min with 10 µl of DMSO solutions of 
drugs and reference antioxidants (to be a final 
concentration of 10-200 µM). The reagent solution of 
volatile sevoflurane was prepared according to its 
quantitative chromatographic method reported by 
Burrows [16]. Just before analysis, sevoflurane chilled 
at 4ºC in an ice bath was added to a volumetric flask, 
and then the flask was diluted to volume with DMSO 
chilled to 20ºC. An aliquot (10 µl) of the prepared 
dilute solution was subjected to the incubation with 
liposome suspensions. A corresponding volume 
(0.25%, v/v) of DMSO vehicle was added for controls. 
The resulting suspensions were incubated with 20 μl of 
a peroxynitrite solution in 0.1 M NaOH (to be a final 
concentration of 20 µM) to peroxidize membrane 
lipids. DPPP is non-fluorescent, but membrane-
incorporated DPPP quantitatively reacts with a lipid 
hydroperoxide to produce a fluorescent phosphine 
oxide in lipid bilayer membranes [17]. After the 
incubation at 37ºC for 10 min, the liposome 
suspensions were fluorometrically analyzed at 355 nm 
for excitation and at 382 nm for emission. When the 
peroxynitrite-induced increases of fluorescence 
intensity reached a plateau, the lipid peroxidation was 
defined as completed (100%). The lipid peroxidation-
inhibition percentages were determined by comparing 
the fluorescence intensity with controls. DMSO used as 
a vehicle might additionally increase the lipid 
peroxidation-inhibitory effects of the tested drugs 
because it has the antioxidant property to reduce lipid 
peroxidation [18]. Therefore, the fluorescence intensity 
of liposome suspensions treated with DMSO alone was 
subtracted from that of liposome suspensions treated 
with drugs plus DMSO so that the determined effects 
were not affected by DMSO. 
Membrane interaction 
DPH-labeled biomimetic membranes with the lipid 
bilayer structure were prepared with phospholipids and 
cholesterol (10 mM for total lipids) to be unilamellar 
vesicles suspended in Dulbecco’s phosphate-buffered 
saline of pH 7.4 as reported previously [19]. The molar 
ratio of DPH to total lipids was 1:200 and the 
membrane lipid composition was the same as that of 
liposomes described above. The potencies to interact 
with biomimetic membranes and change the membrane 
fluidity were determined as reported previously [20]. In 
brief, drugs and reference antioxidants dissolved in 
DMSO were applied to the membrane preparations so 
that a final concentration was 1-200 µM. The 
concentration of DMSO vehicle was adjusted to be 
0.25% (v/v) of the total volume so as not to affect the 
fluidity of intact membranes because DMSO alters the 
biophysical property of biomembranes [21]. Control 
experiments were conducted with an equivalent volume 
of DMSO. After the reaction at 37ºC for 30 min, DPH 
fluorescence polarization was measured by an RF-540 
spectrofluorometer (Shimadzu; Kyoto, Japan) equipped 
with a polarizer at 360 nm for excitation and at 430 nm 
for emission. Polarization values were calculated by the 
formula “(IVV – GIVH) / (IVV + GIVH)” in which I is the 
fluorescence intensity and the subscripts V and H refer 
to the vertical and horizontal orientation of the 
excitation and emission polarizer, respectively. The 
grating correction factor (G = IHV/IHH) was used to 
correct the polarizing effects of a monochromator. 
Decreasing and increasing polarization changes from 
controls mean an increase of membrane fluidity 
(membrane fluidization) and a decrease of membrane 
fluidity (membrane rigidification), respectively.
 
Statistical analysis 
All results are expressed as mean ± SEM (n = 5 for 
lipid peroxidation inhibition experiments and n = 7 for 
membrane interaction experiments). Data were 
analyzed by a one-way analysis of variance (ANOVA) 
followed by a post hoc Fisher’s protected least 
significant difference (PLSD) test using StatView 
version 5.0 (SAS Institute; Cary, NC, USA). P < 0.05 
was considered as significant for all comparisons. 
 
RESULTS 
Lipid peroxidation inhibition 
All the tested general anesthetics, local anesthetics and 
phenol derivatives concentration-dependently inhibited 
the peroxynitrite-induced peroxidation of membrane 
lipids as well as antioxidant α-tocopherol, quercetin 
and EGCG (Fig.2). Inhibitory effects varied among 
drugs, showing that the inhibition at 10 µM was 
greatest in propofol, followed by guaiacol, thiopental, 
thymol, phenol, midazolam, diazepam, lidocaine, 
eugenol, procaine, bupivacaine, ropivacaine, 
sevoflurane, ketamine, mepivacaine and prilocaine. 
They showed greater inhibition at higher concentrations 
(data not shown). 
Membrane interaction 
Lipid peroxidation-inhibiting propofol, local 
anesthetics and phenol derivatives interacted with 
biomimetic membranes to increase the membrane 
fluidity at 1-200 µM as shown by polarization 
decreases (Fig.3). Representative antioxidant drugs 
such as propofol, lidocaine and bupivacaine fluidized 
biomimetic membranes in a concentration-dependent 
manner. Reference antioxidants also interacted with 
biomimetic membranes at 10 µM, although they 
decreased the membrane fluidity. The membrane 
effects of flavonoid antioxidants were not determined  
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Figure 2.  
Inhibitory effects of general anesthetics, 
local anesthetics, phenol derivatives and 
reference antioxidants on membrane lipid 
peroxidation.  
The liposomes of DPPP-incorporated lipid 
bilayers were treated with 10 μM drugs and 
antioxidants, and then peroxidized with 
20 μM peroxynitrite, followed by the 
fluorometric analysis to determine the lipid 
peroxidation inhibition.  
Values represent mean ± SEM (n = 5).  








Figure 3.  
Membrane interactions of propofol,  
local anesthetics, phenol derivatives and 
reference antioxidants.  
Drugs and antioxidants were reacted at the 
indicated concentrations with DPH-labeled 
biomimetic membranes and their induced 
changes in membrane fluidity were 
determined by measuring fluorescence 
polarization.  
Values represent mean ± SEM (n = 7).  
*P < 0.05 and **P < 0.01 vs control. 
 
 
at higher concentrations because they have the property 
to quench the fluorescence of a membrane probe DPH 
at high micromolar concentrations [22]. 
Antioxidant and membrane activity relation 
The lipid peroxidation-inhibitory effects of local 
anesthetics and phenol derivatives were plotted against 
their induced polarization changes indicating the 
membrane fluidization (Fig.4). Although all the tested 
antioxidant drugs interacted with biomimetic 
membranes, the linear regression analysis showed that 
the antioxidant activity did not necessarily correlate to 
the membrane-interacting potency. Reference 
antioxidants interacted with biomimetic membranes, 
but the resultant fluidity modification (membrane 
rigidification) was qualitatively different from that of 
antioxidant drugs (membrane fluidization). 
DISCUSSION 
Main findings of this study are: (1) different drugs such 
as general anesthetics, local anesthetics and phenol 
derivatives inhibit the peroxynitrite-induced membrane 
lipid peroxidation with varying inhibition potencies; (2) 
lipid peroxidation-inhibiting drugs commonly interact 
with biomimetic membranes to increase the membrane 
fluidity, while their membrane-interacting potencies do 
not necessarily agree with their lipid peroxidation-
inhibiting ones; and (3) all the reference antioxidants 
interact with the membranes, but they decrease the 
membrane fluidity in contrast to the membrane-
fluidizing effects of antioxidant drugs. 
Since surgery is referred to as a pathological condition 
to enhance the generation of reactive oxygen/nitrogen 
species, one of important subjects in the perioperative  
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Figure 4. Lipid peroxidation-inhibiting and membrane-interacting 
potencies. The inhibitions (%) by local anesthetics and phenol 
derivatives were plotted against their induced DPH polarization 
changes. 
 
period is to modulate or reduce the oxidative/nitrative 
stress of patients undergoing surgery and anesthesia. 
Peroxynitrite mediates oxidative/nitrative stress, 
ischemia-reperfusion injury, surgery-relating complica-
tion and cardiovascular damage through the lipid 
peroxidation of biomembranes [14, 23, 24]. Drugs with 
the anti-lipid-peroxidative activity would be effective 
in reducing the biological damages by reactive 
oxygen/nitrogen species. When treating the membrane 
preparations with peroxynitrite of a pathologically 
relevant concentration, the induced lipid peroxidation 
was inhibited by various anesthetic drugs and phenol 
derivatives. The latter antioxidants, including phenol, 
guaiacol, eugenol and thymol, are commonly used for 
the purpose of disinfection and analgesia. General 
anesthetic, local anesthetic and disinfectant/analgesic 
drugs, all of which are able to inhibit lipid peroxida-
tion, may be protective against oxidative/nitrative stress 
as previously suggested for anesthesia-related drugs to 
modify oxidative/nitrative stress and ischemia-
reperfusion injury [4, 7, 25]. 
Propofol inhibits lipid peroxidation by two mechanisms 
in which it reacts with lipid peroxyl radicals to form the 
relatively stable phenoxyl radicals and scavenges 
peroxynitrite to experimentally inhibit peroxynitrite-
induced chemiluminescence [26]. Its relating phenols 
with the hydrogen-donating property similarly show the 
antioxidant ability to inhibit lipid peroxidation [27]. 
Lidocaine and procaine potentially scavenge hydroxyl 
radicals or hydrogen peroxide [28]. However, different 
types of drugs: general anesthetics, local anesthetics 
and disinfectant/analgesic phenols showed lipid 
peroxidation-inhibitory effects in common with them, 
suggesting the possibility that the mechanism other 
than scavenging radicals and depressing reactive 
species production may additionally contribute to their 
antioxidant activity. 
The lipid peroxidation inhibited by antioxidants is 
associated with their properties not only to scavenge 
radicals but also to act on membrane lipid molecules 
[29]. The lipid peroxidation inhibition in membrane 
systems is more suitable for evaluating the antioxidant 
potency than the radical scavenging in homogeneous 
non-membrane systems [27]. The susceptibility to 
reactive oxygen/nitrogen species relates to the fluidity 
of lipid membranes [30]. Since unsaturated lipid 
components in membranes are the primary target of 
oxidants, lipid oxidizability is enhanced with an 
increase in the unsaturation degree of membrane-
constituting phospholipids which makes membrane 
lipid bilayers more fluid. While thiopental, diazepam, 
midazolam, ketamine and volatile anesthetics have 
been proved to inhibit lipid peroxidation in this study, 
all of them were previously reported to interact with 
biological and artificial membranes to increase their 
fluidity [31-35]. With respect to other drugs tested for 
the antioxidant activity, propofol, local anesthetics with 
a substituted benzene ring like lidocaine and phenol 
derivatives have a close analogy in structure, 
pharmacological feature and the mode of membrane 
action as reported previously [36, 37]. Therefore, the 
present membrane interaction study focused on 
antioxidant propofol, local anesthetics, disinfectant/ 
analgesic phenols. Consequently, they were 
characterized to interact with lipid bilayer membranes 
and change their fluidity. The perioperatively used 
drugs like β1-blockers also show both lipid 
peroxidation-inhibitory and membrane-fluidizing 
effects [38]. The degree of lipid peroxidation correlates 
to that of membrane fluidity change [39]. Peroxynitrite 
was reported to peroxidize membrane lipids and 
decrease the fluidity of liposomal phospholipid 
membranes concentration-dependently at 0.1-50 µM 
[40]. Radicals and antioxidant molecules are likely to 
interact more efficiently in the membrane lipid 
environments fluidized by propofol and phenolic 
compounds [13, 15, 41]. The activity to interact with 
lipid bilayers and increase the membrane fluidity would 
produce the inhibition of membrane lipid peroxidation 
cooperatively with the radical scavenging activity. 
In comparisons of structurally-related drugs, the rank 
order of lipid peroxidation-inhibitory effects is propofol 
> guaiacol > thymol > phenol > eugenol and that of 
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membrane-fluidizing effects is propofol > thymol > 
guaiacol > phenol > eugenol. The basic structure of 
phenol and certain substituents at the ortho-position (an 
isopropyl group in propofol and thymol, and a 
methoxyl group in guaiacol) appear to potentiate lipid 
peroxidation inhibition and membrane interaction, but a 
substituent at the para-position (an allyl group in 
eugenol) reduces both. Such relations are almost 
consistent with the previous report [15]. 
The propagation of oxidant and antioxidant molecules 
in lipid bilayers is a rate- or efficiency-limiting step of 
lipid peroxidation. Membrane fluidity is a determinant 
of lipid peroxidation rates and the antioxidant potency 
of radical scavengers requires the membrane 
environment [42]. General anesthetic, local anesthetic 
and disinfectant/analgesic drugs, all of which share 
both effects to inhibit lipid peroxidation and fluidize 
membranes, are speculated to interact more efficiently 
with radicals in more fluid membrane lipid bilayers 
[43]. Their membrane-fluidizing effects could favor the 
antioxidant capability by making the interaction 
between antioxidant molecules and radicals more 
efficient [13]. 
Antioxidant α-tocopherol, quercetin and EGCG, which 
scavenge radicals and inhibit lipid peroxidation, 
interact with biomimetic membranes but rigidify them 
in contrast to anesthetics and phenol derivatives. These 
α-tocopherol and flavonoids preferentially partition into 
the internal hydrophobic membrane regions and 
decrease the fluidity referring to the motional freedom 
of molecules in lipid bilayers as indicated by the 
polarization increase of DPH to localize in the 
hydrocarbon core of membranes. Propofol, local 
anesthetics and disinfectant/analgesic phenols are also 
considered to affect the same membrane regions 
because DPH was used for analyzing the membrane 
interactions of these drugs. Unlike such membrane-
fluidizing drugs, however, the membrane rigidification 
by reference antioxidants could lead to the inhibition of 
lipid peroxidation by hampering the diffusion of 
radicals and thereby decreasing the kinetics of radical 
reactions in membrane lipid environments [44]. 
Anyway, the modification of membrane fluidity is 
presumed to be, at least in part, responsible for the 
inhibitory effects of perioperatively used drugs on 
membrane lipid peroxidation. 
The clinical implications of lipid peroxidation-
inhibiting drugs may be argued about their in vivo 
effects. General anesthetics, local anesthetics and 
disinfectant/analgesic phenols not only inhibit lipid 
peroxidation but also interact with lipid membranes at 
clinically relevant concentrations [15, 45]. Amphiphilic 
or hydrophobic drugs like anesthetics and analgesics 
are concentrated in lipid bilayers to show their intra-
membrane concentrations much higher than their 
concentrations in the bulk aqueous phase [46, 47]. The 
potential effects of antioxidant drugs on lipid 
peroxidation would lead to the protection against the 
pathological membrane states associated with 
oxidative/nitrative stress.
 
In addition to their inherent effects, propofol and other 
drugs to inhibit lipid peroxidation may be effective in 
reducing oxidative/nitrative stress in the perioperative 
period. The membrane interaction possibly underlying 
lipid peroxidation-inhibitory effects could be used as a 
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